Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.
Sec. Inflammation
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1488324

Short-term fasting before living kidney donation has an immune-modulatory effect

Provisionally accepted
Christiaan A.J. Oudmaijer Christiaan A.J. Oudmaijer 1,2,3*Daphne Komninos Daphne Komninos 1,3Rutger A. Ozinga Rutger A. Ozinga 1,3Kimberley Smit Kimberley Smit 1,3Nina E.M. Rozendaal Nina E.M. Rozendaal 4Jan H.J. Hoeijmakers Jan H.J. Hoeijmakers 1,3,5,6Wilbert P. Vermeij Wilbert P. Vermeij 1,3Joachim G Aerts Joachim G Aerts 4Jan N.M. IJzermans Jan N.M. IJzermans 2Marcella Willemsen Marcella Willemsen 4
  • 1 Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands
  • 2 Erasmus MC Transplant Institute, Erasmus University Medical Center Rotterdam, Rotterdam, Netherlands
  • 3 Oncode Institute, Utrecht,, Netherlands
  • 4 Department of Pulmonary Medicine, Erasmus Medical Center, Rotterdam, Netherlands
  • 5 Department of Molecular Genetics, Erasmus Medical Center, Rotterdam, Netherlands
  • 6 Institute for Genome Stability in Ageing and Disease and Cologne Excellence Cluster for Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, North Rhine-Westphalia, Germany

The final, formatted version of the article will be published soon.

    Background: Short-Term Fasting (STF) is an intervention reducing the intake of calories, without causing undernutrition or micronutrient-related malnutrition. It aims to systemically improve resilience against acute stress. Several (pre-)clinical studies have suggested protective effects of STF, marking the systemic effects STF can induce in respect to surgery and ischemia-reperfusion injury. In addition, STF also affects the number of circulating immune cells. We aim to determine the effect of STF on the abundance and phenotype of different immune cell populations. Methods: Thirty participants were randomly selected from the FAST clinical trial, including living kidney donors, randomised to an STF-diet or control arm. In an observational cohort sub-study we prospectively included 30 patients who donated blood samples repeatedly during study runtime. Using flow cytometry analyses, immune cell phenotyping was performed on peripheral blood mononuclear cells. Three panels were designed to investigate the presence and activation status of peripheral T cells, B cells, dendritic cells (DCs) and myeloid cells. Results: Eight participants were excluded due to sample constraints. Baseline characteristics showed no significant differences, except for fasting duration. Weight changes were minimal and non-significant across different time intervals, with slight trends towards long-term weight loss pre-surgery. Glucose, insulin, and βhydroxybutyrate levels differed significantly between groups, reflecting adherence to the fasting diet. Flow cytometry and RNA sequencing analysis revealed no baseline differences between groups, with high variability within each group. STF changes the levels and phenotype of immune cells, reducing the abundance and activation of T cells, including regulatory T cells, increased presence of (naïve) B cells, and elevation of type 1 conventional DCs (cDC1s). In addition, a decrease in central memory T cells was observed. Discussion: In this study, we observed significant changes due to fasting in B cells, T cells, and DCs, specifically towards less specialized lymphocytes, suggesting an arrest in B and T cell development. Further research should focus on the clinical implications of changes in immune cells and significance of these observed immunological changes. Conclusion: STF results in reduced numbers and activation status of T cells and Tregs, increased presence of (naïve) B cells, and elevation of cDC1s.

    Keywords: Short-term fasting, Acute inflammatory response, immune response, Cell population analysis, Caloric Restriction

    Received: 29 Aug 2024; Accepted: 13 Jan 2025.

    Copyright: © 2025 Oudmaijer, Komninos, Ozinga, Smit, Rozendaal, Hoeijmakers, Vermeij, Aerts, IJzermans and Willemsen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Christiaan A.J. Oudmaijer, Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.